CASI Pharmaceuticals Inc (NASDAQ:CASI)

1.64
Delayed Data
As of 3:59pm ET
 0.00 / 0.00%
Today’s Change
1.07
Today|||52-Week Range
2.09
+23.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues3.7M1.9M669.3K0.00
 
 
 
 
Depreciation And Amortization70.4K38.1K20.5K17.4K
 
 
 
 
 
 
Operating ExpensesGross Income3.6M-----17.4K
 
 
 
General Expenses8.2M6.5M5.2M5.7M
 
 
 
 
 
Research And Development4.8M3.5M2.4M2.7M
 
 
 
 
 
Total Operating Expenses8.2M6.5M5.2M5.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.5M-4.6M-4.5M-5.7M
 
 
 
 
 
Extraordinary Charge-3.0M0.000.000.00
 
 
Interest Expense On Debt540.2K0.0010.0M0.00
 
 
 
Other Expenses-26.3K9.5K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.1M-4.6M-14.5M-5.7M
 
 
 
 
 
Preferred Dividend-1.0M-1.0M-335.0K0.00
 
 
 
 
Net Income-8.1M-4.6M-14.5M-5.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.7M11.8M19.1M26.1M
 
 
 
 
 
Shares To Calculate EPS Diluted9.7M11.8M19.1M26.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.94-$0.47-$0.78-$0.22
 
 
 
 
 
EPS Diluted-$0.94-$0.47-$0.78-$0.22
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account